Cervical Malignancies and Potential Pap Pitfalls
Rachel Conrad, MD
Rosemary Zuna, MD
Due to successful cervical screening programs, malignant Pap tests are decreasing in number in most laboratories. This leads to fewer opportunities for cytotechnologists and cytopathologists to view cervical malignancies on Pap tests and develop familiarity with cytomorphologic features of malignancy. As the recommended interval between Pap tests increases, prompt recognition of these features will become even more essential in providing quality patient care. This webinar reviews our experience with numerous Paps from confirmed cervical malignancies (squamous and glandular) with pertinent clinical, HPV, and histopathologic data. Key tips and challenging cases will also be discussed.
|Earn 2 credits per webinar|